跳至主要内容
临床试验/NCT00488865
NCT00488865已完成不适用

RexMedical- Option* Vena Cava Filter IDE Study

Rex Medical19 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2006年10月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
100
试验地点
19
主要终点
Percentage of Participants With Clinical Success

研究概览

简要总结

This study is designed to evaluate the safety and efficacy of the RexMedical Option* Vena Cava Filter in the treatment of patients who are at increased risk for Pulmonary Embolism and require caval interruption.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient is at least 18 years of age
  • Patient requires temporary or permanent caval interruption

排除标准

  • Patient has pre-existing filter implanted in her/her vasculature or has undergone filter retrieval within 60 days prior to study device implant
  • Patient is currently enrolled in another investigational device or drug trial

结局指标

主要结局

Percentage of Participants With Clinical Success

时间窗: up to 180 days

Placement Technical Success without subsequent pulmonary embolism, significant filter migration, symptomatic caval thrombosis or other complication requiring filter removal or invasive intervention to address condition.

Percentage of Participants With Retrieval Clinical Success

时间窗: upto 175 days

Intact filter retrieval via percutaneous techniques from the vasculature without associated injury or damage to the vena cava requiring intervention.

次要结局

  • Placement Technical Success(Immediately post placement procedure)

研究者

发起方
Rex Medical
申办方类型
Industry

研究点 (19)

Loading locations...

相似试验

RexMedical- Option* Vena Cava Filter IDE Study | 临床试验